Axogen (AXGN) Total Current Liabilities (2010 - 2026)
Axogen (AXGN) recorded quarterly Total Current Liabilities of $26.0 million in Q1 2026, up 10.43% quarter-over-quarter from $23.6 million in Q4 2025, and up 19.63% on a YoY basis from $21.7 million in Q1 2025.
Axogen (AXGN) Total Current Liabilities (2010 - 2026) Analysis & Trends
Axogen's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $26.0 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 19.63% year-over-year to $26.0 million; the TTM figure through Mar 2026 stood at $26.0 million (up 19.63% YoY), while the FY2025 annual figure was $23.6 million, down 23.04% from the prior year.
- Total Current Liabilities was $26.0 million for Q1 2026 at Axogen, up from $23.6 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $30.6 million in Q4 2024 to a low of $21.2 million in Q1 2023.
- Historically, Total Current Liabilities has averaged $24.7 million across 5 years, with a median of $23.6 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Total Current Liabilities rose 28.11% in 2023, then declined 23.04% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $23.8 million in 2022, then climbed by 28.11% to $30.4 million in 2023, then climbed by 0.59% to $30.6 million in 2024, then dropped by 23.04% to $23.6 million in 2025, then climbed by 10.43% to $26.0 million in 2026.
- The last three Total Current Liabilities figures came in at $26.0 million (Q1 2026), $23.6 million (Q4 2025), and $28.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 9.50 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.22 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.15 Bn |
| 10 | Axogen | 2.32 Bn | 2.22 Bn | 46.19 Mn | 26.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.01 Mn |
| Dec 31, 2025 | 23.56 Mn |
| Sep 30, 2025 | 28.01 Mn |
| Jun 30, 2025 | 24.98 Mn |
| Mar 31, 2025 | 21.75 Mn |
| Dec 31, 2024 | 30.61 Mn |
| Sep 30, 2024 | 23.03 Mn |
| Jun 30, 2024 | 23.42 Mn |
| Mar 31, 2024 | 22.93 Mn |
| Dec 31, 2023 | 30.43 Mn |
| Sep 30, 2023 | 26.65 Mn |
| Jun 30, 2023 | 23.93 Mn |
| Mar 31, 2023 | 21.24 Mn |
| Dec 31, 2022 | 23.75 Mn |
| Sep 30, 2022 | 23.55 Mn |
| Jun 30, 2022 | 23.60 Mn |
| Mar 31, 2022 | 22.95 Mn |
| Dec 31, 2021 | 24.29 Mn |
| Sep 30, 2021 | 23.36 Mn |
| Jun 30, 2021 | 21.63 Mn |